Ozempic Proves 1 Breakthrough Is All You Need by Matthew Clark | Sep 4, 2023 | Stock Power Daily Novo Nordisk (NYSE: NVO) stock is rallying thanks to Ozempic, a diabetes drug that many are using for weight loss. ...
Wood Isn’t Worried After Market Bears Sink ARKK (We Aren’t Either) by Adam O'Dell | Jul 8, 2022 | Investing Cathie Wood is one of the greatest investors of our time. Here's why we aren't worried her ARK Innovation ETF ...
Be a Biotech Value Investor (Start With 2 Stocks!) by Adam O'Dell | Feb 21, 2022 | Investing Do you want to be a biotech value investor? It's possible to target solid companies trading at cheaper valuations in ...
Biotech ETF Showdown (IDNA vs. ARKG vs. BBH) by Matthew Clark | Oct 23, 2021 | Markets, Podcast Biotech is one of the fastest-growing markets today. ETFs are a great way for investors to get started in this ...
Biotech IPO Buzz: Here’s the Best Way to Play It by Adam O'Dell | Oct 11, 2021 | Investing The genomics and biotech revolution is here. Read this before you add a biotech IPO (initial public offering) to your ...
How Far-Fetched Is Jeff Bezos’ Plan to Live Forever? by Adam O'Dell | Sep 10, 2021 | Investing Jeff Bezos is throwing money at a startup that is researching a way to reverse the aging process. Is genomics ...
Be a Genomics Landlord With One High-Growth Biotech REIT by Adam O'Dell | Sep 3, 2021 | Investing Genomics has true potential, and that opens up many avenues to invest in this mega trend. Here's a high-growth biotech ...
Large-Cap Biotech Stock Success Will Fuel a Small-Cap Surge by Adam O'Dell | Aug 27, 2021 | Markets Large-cap biotech stocks have enjoyed a nice run up thanks to the COVID-19 vaccine race. Here's why that's great news ...
Biotech Stock Tip: Make the Most of the “Novel” Drug Rush by Matthew Clark | Jun 12, 2021 | Investing, Podcast In this episode of The Bull & The Bear, we examine how novel drug approvals can impact biotech stocks like ...
Don’t Count on Biogen Stock Gains — Alzheimer’s Drug Has Baggage by Matthew Clark | Jun 10, 2021 | Investing, Podcast In this episode of The Bull & The Bear, I tell you if Biogen stock (Nasdaq: BIIB) is a buy ...